Gsk annual depreciation and amortization
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Gsk Depreciation & Amortization Growth & History (GSK)
Gsk's depreciation and amortization was £2.31B for fiscal 2025.
View full Gsk company overviewGsk annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | £2.31B | −£237.0M | −9.29% |
| 2024 | 2024-12-31 | £2.55B | £257.0M | +11.20% |
| 2023 | 2023-12-31 | £2.29B | £147.0M | +6.85% |
| 2022 | 2022-12-31 | £2.15B | £25.0M | +1.18% |
| 2021 | 2021-12-31 | £2.12B | £72.0M | +3.51% |
| 2020 | 2020-12-31 | £2.05B | −£284.0M | −12.17% |
| 2019 | 2019-12-31 | £2.33B | £478.0M | +25.75% |
| 2018 | 2018-12-31 | £1.86B | −£66.0M | −3.43% |
| 2017 | 2017-12-31 | £1.92B | £148.0M | +8.34% |
| 2016 | 2016-12-31 | £1.77B | £144.0M | +8.83% |
| 2015 | 2015-12-31 | £1.63B | — | — |
Gsk quarterly depreciation and amortization
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | £2.29B | £1.13B | +97.58% |
| Q1 2026 | 2026-03-31 | £463.0M | — | — |
| Q4 2025 | 2025-12-31 | −£406.0M | — | — |
| Q3 2025 | 2025-09-30 | £738.0M | — | — |
| Q2 2025 | 2025-06-30 | £1.16B | — | — |
Gsk depreciation and amortization trends
Over the last five fiscal years, Gsk's depreciation and amortization increased from £2.05B to £2.31B, a change of £264.0M. The latest reported quarter, Q2 2026, shows £2.29B.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Gsk source filings ↗